← brief for 2026-11-02 · Slowing decline

GLP-1 Receptor Agonists Versus Empagliflozin or Dapagliflozin in the MASLD-Heart Failure Phenotype: An Exploratory Propensity-Matched Cohort Study.

Article C Peer reviewed Observational

Key takeaways

This study compared two types of drugs in people with liver disease and heart failure. It used existing medical records to see which drug group had better outcomes. It is an observational study, so it shows a link but not proof of cause. The results may help doctors choose the right drug for complex patients.

Who did this work

Gautam N · Huynh TM · Truong HH · Duong N

Source

Article · PubMed, the drug frontier · 2026 Nov 2
https://pubmed.ncbi.nlm.nih.gov/42969666/